Syndax Pharmaceuticals Inc (SNDX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SNDX Annual Balance Sheets →
The balance sheet data below highlights changes in Syndax Pharmaceuticals Inc's financial position over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent336.48
Short-term Investments, Total0.00
Deposits Assets, Current AS6.41
Cash & Short-term Investments342.00
Accounts receivable45.07
Other Receivables3.70
Notes Receivable, Current2.66
Inventories33.16
Other Current Assets0.00
Prepaid Expense And Other Assets Current21.80
Total Current Assets675.04
Equipment/Property/Plant Net0.65
Long-term investments27.22
Deferred, Prepaid and Other Assets, Noncurrent5.97
Other Assets, Noncurrent220.55
Operating Lease Right Of Use Asset1.21
Total Assets703.65
Liabilities
Accounts Payable, Current AC4.87
Accrued Liabilities And Other Liabilities11.38
Loans Payable to Bank, Current LO1344.03
Other Liabilities, Current0.00
Total Current Liabilities99.68
Long-term Debt Convertible244.09
Total Long-term Debt244.09
Other liabilities, Noncurrent84.18
Total Liabilities688.55
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,613.85
Retained Earnings / Accumulated Deficit-1,598.62
Accumulated Other Comprehensive Income-0.14
Other Equity0.00
Common Stockholder's Equity15.10
Total Stockholder's Equity15.10
Liabilities & Stockholder's Equity703.65
4 historic quarters locked

Sign in to unlock the full Syndax Pharmaceuticals Inc balance sheet history.

About Syndax Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-332750

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.